Fact Sheet for Healthcare Providers: Emergency Use Authorization for Molnupiravir
收藏官方服务：
资源简介：
Fact Sheet for Healthcare Providers: Emergency Use Authorization for Molnupiravir
应用场景：
创建时间：
2022-02-01
相关数据集
SUPPLEMENTARY FILE 2. THE ASSOCIATION BETWEEN CONVALESCENT PLASMA AND THE RISK OF MORTALITYSupplementary file 2: Association between convalescent plasma and the risk of mortality among patients with COVID-19: A meta-analysis
Supplementary file 2. The association between convalescent plasma and the risk of mortality.Association between convalescent plasma and the risk of mortality among patients with COVID-19: A meta-analy
DataCite Commons2021-04-05 更新90
REPOSITORY COMVIVIR .xlsx
This research evaluated the effect of Maraviroc and/or Favipiravir plus systemic steroids versus systemic steroids only on the viral load of adults with severe COVID-19: clinical trials .COVID-19 has
DataCite Commons2024-01-23 更新70
Biologic correlates of COVID-19 resolution using single cell RNA sequecing
We report a case of full resolution of severe COVID-19 due to convalescent plasma transfusion. Following transfusion, the patient showed fever remission, improved respiratory status, and rapidly decre
NIAID Data Ecosystem40
Supplementary Material for: Effect of Hemadsorption Therapy in Critically Ill Patients with COVID-19 (CYTOCOV-19): A Prospective Randomized Controlled Pilot Trial
Introduction: Immunomodulatory therapies have shown beneficial effects in patients with severe COVID-19. Patients with hypercytokinemia might benefit from the removal of inflammatory mediators via hem
Mendeley Data2024-06-25 更新90
Supplementary Material for: THE ROLE OF IMMUNOMODULATORY THERAPY WITH OXIRIS IN COVID 19 WITH RENAL FAILURE AND IMMUNE DYSFUNCTION.
INTRODUCTION: The main objective of this study is to evaluate the impact of hemoadsorption on the elimination of inflammatory mediators. METHODS: A prospective, bicenter, observational cohort study wa
DataCite Commons2025-05-01 更新50
